late
winter
earli
spring
tabl
headach
malais
abdomin
pain
nausea
vomit
commonli
associ
cough
rhinorrhea
stridor
hoars
conjunct
diarrhea
distinctli
unusu
pharyng
erythema
sometim
palat
petechia
found
examin
tonsil
enlarg
red
patchi
exud
surfac
papilla
tongu
may
red
swollen
lead
design
strawberri
tongu
tender
enlarg
anterior
cervic
lymph
node
often
found
combin
sign
assist
diagnosi
tonsillar
exud
associ
palat
petechia
tender
anterior
cervic
aden
strongli
suggest
group
streptococc
pharyng
often
classic
characterist
absent
patient
streptococc
pharyng
younger
children
may
coryza
crust
nare
gener
adenopathi
chronic
cours
syndrom
known
streptococcosi
scarlet
fever
socal
fine
diffus
red
rash
usual
indic
infect
group
streptococci
rare
seen
children
younger
year
adult
rash
scarlet
fever
caus
infect
group
strain
contain
bacteriophag
encod
product
erythrogen
toxin
usual
erythrogen
pyrogen
exotoxin
scarlet
fever
rash
textur
feel
similar
sandpap
blanch
pressur
begin
face
becom
gener
hour
area
around
mouth
often
appear
pale
comparison
extrem
red
cheek
give
appear
circumor
pallor
accentu
erythema
occur
flexor
skin
creas
especi
antecubit
fossa
pastia
sign
pastia
line
erythema
begin
fade
within
day
within
week
onset
desquam
occur
first
face
progress
downward
often
resembl
seen
subsequ
mild
sunburn
occasion
sheetlik
desquam
occur
around
free
margin
finger
nail
usual
coars
desquam
seen
kawasaki
diseas
differenti
diagnosi
scarlet
fever
includ
kawasaki
diseas
measl
staphylococc
toxic
shock
syndrom
tabl
recent
public
highlight
invas
toxinproduc
group
streptococc
infect
includ
necrot
fasciiri
although
mani
patient
socal
streptococc
toxic
shock
syndrom
also
infect
streptococci
produc
erythrogen
toxin
infect
caus
group
streptococci
associ
unusu
sever
streptococc
toxic
shock
syndrom
associ
commonli
primari
cutan
focu
infect
rather
pharyng
focu
infect
scarlet
fever
still
explain
simpl
term
patient
famili
streptococc
pharyng
rash
streptococc
pharyng
identifi
mainli
welldefin
epidem
world
war
ii
endem
unit
state
sinc
case
gener
peak
late
winter
earli
spring
children
year
old
highest
rate
streptococc
pharyng
infect
occur
age
outbreak
document
day
care
center
spread
group
streptococci
classroom
within
famili
common
crowd
live
condit
increas
spread
militari
unit
common
site
streptococc
research
frequent
epidem
devast
effect
troop
train
avail
transmiss
occur
primarili
inhal
organ
larg
droplet
direct
contact
respiratori
secret
pet
seem
signific
reservoir
group
streptococci
untreat
streptococc
pharyng
particularli
contagi
earli
acut
ill
first
week
organ
acquir
appropri
antibiot
therapi
elimin
contagi
within
hour
institut
therapi
children
return
school
mani
patient
bona
fide
group
streptococc
pharyng
classic
sign
symptom
symptom
overlap
substanti
pharyng
caus
agent
howev
presenc
typic
featur
viral
pharyng
low
rate
streptococc
diseas
commun
strongli
suggest
nonstreptococc
etiolog
laboratori
test
option
sign
symptom
suggest
acut
streptococc
pharyng
includ
patient
scarlet
fever
laboratori
diagnosi
strongli
recommend
fig
clinic
score
system
diagnos
acut
streptococc
pharyng
develop
prove
use
use
clinic
criteria
alon
physician
tend
overestim
likelihood
patient
streptococc
infect
g
throat
cultur
use
physician
offic
diagnos
streptococc
pharyng
sinc
earli
plate
swab
posterior
pharynx
tonsil
sheep
blood
agar
identifi
coloni
test
sensit
bacitracinimpregn
disc
gold
standard
diagnost
test
requir
hour
recent
number
rapid
diagnost
test
requir
less
minut
develop
perform
experienc
personnel
rapid
diagnost
test
rapid
strep
antigen
test
highli
specif
gener
use
throat
cultur
standard
specif
reflect
percentag
posit
result
come
patient
truli
harbor
group
streptococci
unfortun
sensit
percentag
trueposit
identifi
group
antigen
detect
rapid
test
problemat
although
sensit
test
typic
optic
immunoassay
oia
technolog
evalu
suffici
recommend
time
inadequ
sensit
rapid
test
coupl
excel
specif
requir
twostep
approach
rapid
streptococc
antigen
test
use
two
swab
obtain
patient
suspect
streptococc
pharyng
one
swab
use
rapid
test
rapid
antigen
detect
test
posit
highli
like
patient
group
streptococci
throat
extra
swab
discard
rapid
test
neg
group
streptococci
may
still
present
thu
extra
swab
process
cultur
routin
fashion
gener
patient
neg
rapid
test
requir
treatment
cultur
verif
particularli
high
index
suspicion
group
streptococci
involv
eg
sever
follow
tonsillar
exud
cervic
adenopathi
palat
petechia
scarlet
fever
recent
exposur
person
streptococc
pharyng
presumpt
treatment
may
appropri
rapid
test
intend
diagnosi
acut
streptococc
pharyng
use
evalu
effect
therapi
posit
result
asymptomat
patient
distinguish
among
infect
colon
carriag
presenc
nonviabl
organ
neg
result
must
confirm
throat
cultur
sever
survey
examin
actual
strategi
use
physician
diagnos
streptococc
pharyng
cochi
et
al
survey
primari
care
physician
decemb
januari
rapid
test
becam
avail
found
approxim
respond
alway
nearli
alway
obtain
throat
cultur
patient
sore
throat
cultur
never
almost
never
obtain
physician
survey
survey
also
found
pediatrician
like
internist
familygener
practition
use
throat
cultur
schwartz
et
survey
pediatrician
diagnost
approach
children
pharyng
optim
approach
defin
use
cultur
alon
backup
neg
rapid
antigen
test
least
patient
use
pediatrician
respond
survey
seventeen
percent
report
use
clinic
find
rapid
test
without
cultur
children
pharyng
obtain
similar
result
recent
nation
survey
us
pediatrician
use
rapid
test
least
time
use
throat
cultur
whenev
rapid
test
neg
use
cultur
alon
use
strategi
recommend
thu
appear
mani
physician
follow
recommend
guidelin
diagnos
streptococc
pharyng
test
patient
serolog
evid
antibodi
respons
extracellular
product
group
streptococci
streptolysin
use
acut
pharyng
episod
serum
antibodi
level
requir
least
day
increas
streptococc
antibodi
test
valid
determin
past
infect
antibodi
often
measur
includ
antistreptolysin
aso
antidnas
b
antihyaluronidas
aht
antibodi
test
desir
evalu
possibl
poststreptococc
ill
one
test
perform
improv
sensit
howev
streptozym
test
wampol
laboratori
cranburi
nj
assay
use
latex
particl
coat
group
streptococcu
broth
cultur
supern
shown
poorli
standard
therefor
recommendedi
primari
goal
therapi
acut
streptococc
pharyng
prevent
develop
arf
treatment
begun
within
day
onset
acut
pharyng
continu
day
effect
prevent
arf
therapi
seem
affect
risk
poststreptococc
agn
antibiot
therapi
also
reduc
suppur
sequela
streptococc
pharyng
peritonsillar
abscess
cervic
aden
addit
prevent
arf
sign
symptom
pharyng
resolv
somewhat
rapidli
patient
treat
earli
fact
document
recent
studi
publish
first
note
sever
decad
ago
sinc
antibiot
therapi
also
termin
contagi
within
hour
institut
appropri
antibiot
therapi
gener
undertaken
soon
diagnosi
support
laboratori
test
although
studi
suggest
earli
treatment
may
increas
rate
recurr
streptococc
pharyng
stunt
immun
respons
care
perform
investig
refut
concept
unnecessarili
delay
therapi
risk
lose
patient
followup
particular
problem
among
patieni
without
establish
sourc
primari
health
care
may
prolong
symptom
lead
loss
addit
time
school
andor
work
extend
period
contagi
antimicrobi
therapi
start
result
cultur
avail
especi
rash
scarlet
fever
present
clinic
featur
highli
suggest
streptococc
infect
therapi
stop
group
streptococci
confirm
rapid
test
throat
cultur
although
mani
physician
unfortun
continu
antibiot
therapi
despit
neg
test
drug
choic
treat
streptococc
pharyng
penicillin
year
despit
widespread
use
penicillin
treat
streptococc
infect
penicillin
resist
among
group
streptococci
develop
penicillin
usual
given
mouth
day
mg
penicillin
v
three
four
time
day
intramuscularli
singl
inject
benzathin
penicillin
unit
patient
weigh
less
pound
kg
million
unit
weigh
pound
kg
effort
improv
complianc
twicedaili
dose
tri
success
shorter
cours
therapi
also
tri
bacteriolog
result
day
therapi
promis
use
intramuscular
benzathin
penicillin
also
allevi
concern
patient
complianc
quit
pain
less
pain
altern
unit
benzathin
penicillin
combin
unit
procain
penicillin
patient
intramuscular
procain
penicillin
alon
insuffici
adequ
level
penicillin
shortliv
lactam
includ
semisynthet
deriv
penicillin
cephalosporin
use
treat
streptococc
pharyng
decreas
frequenc
administr
agent
may
improv
patient
complianc
make
attract
select
circumst
patient
allerg
penicillin
receiv
erythromycin
anoth
antibiot
clindamycin
resist
group
streptococci
erythromycin
report
countri
japan
franc
spain
finland
erythromycin
wide
use
emerg
problem
unit
state
sulfa
drug
includ
sulfamethoxasoletrimethoprim
tetracyclin
chloramphenicol
effect
erad
group
streptococci
pharynx
use
treatment
acut
pharyng
despit
univers
suscept
group
streptococci
penicillin
treatment
fail
erad
streptococci
pharynx
mani
patient
penicillin
resist
caus
treatment
failur
therefor
treatment
failur
puzzl
phenomenon
small
proport
patient
remain
symptomat
thu
character
clinic
treatment
failur
reinfect
differ
strain
group
streptococcu
possibl
intercurr
viral
pharyng
patient
may
noncompli
therapi
appar
treatment
failur
occur
even
among
patient
treat
intramuscular
benzathin
penicillin
patient
chronic
pharyng
carrier
group
streptococci
suffer
new
superimpos
viral
infect
fig
patient
bacteriolog
treatment
failur
asymptomat
identifi
followup
cultur
obtain
practic
gener
unnecessari
patient
compliant
therapi
minim
risk
arf
evid
bacteriolog
failur
rate
may
somewhat
lower
antibiot
penicillin
use
especi
cephalosporin
although
numer
studi
variou
cephalosporin
publish
studi
larg
enough
perform
rigor
enough
prove
class
antimicrobi
superior
penicillin
antibiot
treatment
failur
associ
use
publish
metanalys
suffer
poor
qualiti
mani
includ
studi
semisynthet
deriv
penicillin
dicloxicillin
rifampin
given
oral
penicillin
amoxicillinclavulan
clindamycin
drug
also
use
time
fair
say
antimicrobi
least
effect
penicillin
treat
streptococc
pharyng
broader
spectrum
much
greater
cost
lack
formal
data
concern
prevent
arf
current
releg
secondlin
statu
routin
use
agent
warrant
sever
theori
advanc
explain
bacteriolog
treatment
failur
includ
protect
group
streptococci
oral
flora
toler
group
streptococci
penicillin
streptococci
hide
tonsil
absenc
oral
ttora
particularli
alpha
streptococci
inhibitori
group
streptococci
none
theori
proven
sever
deserv
mention
numer
report
efficaci
antibiot
suggest
possibl
role
flora
penicillin
treatment
failur
howev
patient
popul
studi
bacteriolog
method
use
followup
differ
greatli
among
studi
studi
actual
isol
bacteria
pharynx
tri
correl
presenc
bacteriolog
outcom
treatment
studi
evalu
thepres
e
produc
outcom
treatment
acut
streptococc
pharyng
support
theori
toler
penicillin
inhibit
bacteri
growth
without
kill
discuss
wide
seem
play
role
treatment
failur
perhap
best
explan
asymptomat
persist
ofgroupa
streptococci
appropri
treatment
patient
chronic
colon
group
streptococci
develop
symptom
intercurr
viral
pharyng
ie
retrospect
bonafid
acut
streptococc
pharyng
patient
colon
chronic
group
streptococci
call
chronic
carrier
chronic
carrier
seem
risk
arf
develop
suppur
complic
rare
spread
group
streptococci
commun
reason
exclud
chronic
carrier
school
activ
care
control
studi
caus
chronic
pharyng
carriag
group
streptococci
present
precis
mechan
lead
phenomenon
remain
obscur
theori
includ
advanc
explain
bacteriolog
treatment
failur
chronic
streptococc
carriag
fairli
common
one
studi
children
year
old
present
well
child
care
asymptomat
colon
group
streptococci
even
higher
rate
carriag
sometim
document
carriag
pose
problem
clinician
easi
way
identifi
chronic
carrier
prospect
among
patient
symptom
acut
pharyng
streptococc
antibodi
titer
often
elev
carrier
hut
neither
elev
titer
quantit
throat
cultur
prove
use
clinician
consid
possibl
chronic
streptococc
carriag
patient
multipl
cultureposit
episod
pharyng
especi
symptom
mild
atyp
cultur
obtain
suspect
carrier
symptomfre
receiv
treatment
penicillin
intramuscular
benzathin
penicillin
recommend
elimin
possibl
noncompli
usual
posit
group
streptococci
chronic
carrier
sometim
receiv
multipl
unsuccess
cours
antibiot
therapi
attempt
elimin
streptococci
physician
patient
anxieti
common
develop
streptophobia
part
unproven
gener
untest
therapi
carrier
often
encount
includ
tonsillectomi
prolong
administr
antibiot
use
antibiot
cultur
andor
treatment
pet
none
approach
justifi
time
treat
chronic
carrier
group
streptococci
sever
treatment
option
avail
physician
face
chronic
streptococc
carrier
ignor
problem
stop
obtain
throat
cultur
even
new
symptomat
attack
pharyng
obtain
rapid
test
andor
throat
cultur
time
patient
symptom
sign
suggest
streptococc
pharyng
avoid
obtain
throat
cultur
patient
symptom
typic
viral
ill
cough
rhinorrhea
stridor
hoars
conjunct
diarrhea
treat
penicillin
time
test
posit
treat
one
regimen
establish
effect
termin
chronic
carriag
three
option
first
riski
patient
could
becom
infect
new
strain
group
streptococcu
risk
arf
left
untreat
second
option
simpl
safe
penicillin
appropri
mani
patient
third
option
reserv
particularli
anxiou
patient
famili
individu
histori
arf
live
someon
arf
live
work
nurs
home
chronic
care
facil
hospit
famili
exhibit
pingpong
spread
ie
streptococc
pharyng
bounc
among
famili
member
long
time
two
treatment
regimen
demonstr
effect
intramuscular
benzathin
penicillin
plu
oral
rifampin
mgkgdose
mg
administ
twice
daili
day
begin
day
penicillin
inject
oral
clindamycin
given
day
mgkg
day
mg
divid
three
equal
dose
current
prefer
clindamycin
easier
use
intramuscular
penicillin
plu
oral
rifampin
may
somewhat
effect
antibiot
regimen
demonstr
control
compar
trial
reliabl
termin
chronic
streptococc
carrier
state
success
erad
carrier
state
make
evalu
subsequ
episod
pharyng
much
easier
although
seen
chronic
carriag
recur
reexposur
group
streptococci
patient
seem
remark
suscept
streptococc
pharyng
appropri
antibiot
treatment
episod
result
resolut
symptom
erad
microorgan
followup
throat
cultur
may
need
distinguish
recurr
acut
streptococc
pharyng
frequent
nonstreptococc
pharyng
patient
chronic
carrier
reason
frequent
episod
ofbonafid
acut
streptococc
pharyng
obscur
lack
flora
especi
alpha
streptococci
capabl
inhibit
group
streptococci
unusu
mucos
adher
group
streptococci
intrigu
concept
studi
nasal
spray
alpha
streptococci
prevent
recurr
acut
pharyng
ongo
sweden
role
tonsillectomi
manag
patient
multipl
episod
streptococc
pharyng
remain
controversi
paradis
et
demonstr
fewer
episod
sore
throat
among
children
treat
tonsillectomi
compar
patient
treat
without
surgeri
first
year
oper
patient
enrol
studi
experienc
numer
episod
pharyng
episod
sore
throat
caus
group
streptococci
fact
often
miss
studi
dite
particular
concern
report
tonsillectomi
complic
rate
improv
time
note
among
patient
undergo
tonsillectomi
final
clear
presenc
tonsil
necessari
streptococci
infect
throat
tonsillectomi
recommend
present
except
unusu
circumst
episod
pharyng
caus
virus
distinguish
viral
streptococc
pharyng
clinic
ground
alon
difficult
certain
clue
may
help
physician
accompani
symptom
rhinifi
croup
laryng
hoars
conjunct
diarrhea
common
viral
infect
hut
rare
streptococc
pharyng
mani
viral
agent
produc
pharyng
tabl
virus
caus
distinct
clinic
syndrom
diagnos
without
laboratori
test
parainfluenza
influenza
virus
rhinovirus
coronavirus
respiratori
syncyti
viru
typic
produc
symptom
coryza
cough
well
mild
pharyng
influenza
viru
infect
may
caus
fever
cough
headach
malais
myalgia
cervic
adenopathi
addit
pharyng
adenovirus
caus
fever
cervic
lymph
node
enlarg
pharyng
erythema
follicular
hyperplasia
tonsil
exud
conjuct
occur
associ
adenovir
pharyng
result
syndrom
call
pharyngoconjunctiv
fever
enterovirus
coxsacki
virus
echoviru
caus
sore
throat
especi
summer
throat
may
slightli
red
tonsillar
exud
cervic
adenopathi
unusu
symptom
resolv
within
day
enterovirus
caus
two
specif
syndrom
involv
oropharynx
herpangina
caus
coxsacki
virus
b
echoviru
character
distinct
discret
pain
graywhit
papulovesicular
lesion
distribut
posterior
oropharypx
vesicl
mm
diamet
surround
initi
halo
erythema
ulcer
fever
may
reach
coxsacki
viru
caus
handfootmouth
diseas
pain
vesicl
may
ulcer
occur
throughout
oropharynx
vesicl
also
develop
palm
sole
sometim
trunk
extrem
fever
present
case
mani
children
appear
ill
primari
infect
herp
simplex
viru
usual
produc
high
fever
acut
gingivostomat
young
children
vesicl
becom
ulcer
develop
throughout
anterior
portion
mouth
includ
lip
posterior
pharynx
spare
high
fever
common
pain
intens
intak
oral
fluid
often
impair
may
lead
dehydr
herpet
gingivostomat
may
last
week
experi
infant
toddler
measl
epidem
chicago
highlight
promin
earli
oral
find
addit
high
fever
cough
coryza
conjunct
pharynx
may
intens
diffus
erythemat
without
tonsillar
enlarg
exud
presenc
koplik
spot
pathognomon
white
bluewhit
enanthem
measl
buccal
mucosa
near
mandibular
molar
provid
evid
measl
rash
develop
acut
exud
pharyng
often
occur
infecti
mononucleosi
im
caus
primari
infect
epsteinbarr
viru
ebv
im
usual
associ
hepatosplenomegali
gener
lymphadenopathi
pharyng
variabl
sever
latter
may
quit
sever
signific
tonsillar
hypertrophi
erythema
impress
tonsillar
exud
close
resembl
streptococc
pharyng
region
lymph
node
may
particularli
enlarg
tender
im
occur
promin
adolesc
young
adult
frequent
milder
subclin
among
preadolesc
incub
period
patient
typic
experi
abrupt
onset
malais
fatigu
fever
headach
follow
close
pharyng
enlarg
tonsil
exud
cervic
adenopathi
gener
adenopathi
hepatosplenomegali
often
follow
quickli
fever
pharyng
typic
last
week
wherea
lymphadenopathi
hepatosplenomegali
subsid
week
malais
lethargi
persist
sever
month
lead
impair
school
work
perform
acut
exud
pharyng
associ
hepatomegali
splenomegali
gener
lymphadenopathi
strongli
suggest
im
earli
diseas
im
may
difficult
distinguish
caus
pharyng
includ
streptococc
pharyng
laboratori
find
includ
atyp
lymphocytosi
heterophil
antibodi
react
bovin
erythrocyt
often
detect
monospot
test
specif
antibodi
ebv
viral
capsid
antigen
vca
earli
antigen
ea
epsteinbarr
nuclear
antigen
ebna
acut
im
usual
associ
posit
heterophil
test
antibodi
vca
ea
serolog
evid
im
sought
splenomegali
featur
present
symptom
persist
beyond
day
regardless
throat
cultur
result
sever
bacteria
group
streptococci
associ
pharyng
state
develop
countri
immun
diphtheria
toxoid
hand
oi
diphtheria
case
recogn
annual
unit
state
usual
occur
unimmun
individu
fatal
rate
recent
larg
outbreak
diphtheria
russia
infect
document
sever
travel
western
europ
emphas
need
support
immun
program
acut
tonsillar
pharyng
diphtheria
character
anorexia
malais
lowgrad
fever
sore
throat
classic
grayish
membran
form
within
day
tonsil
pharyng
wall
may
extend
larynx
trachea
cervic
adenopathi
may
associ
appear
bull
neck
mild
case
membran
slough
day
patient
recov
sever
case
diseas
may
progress
prostrat
stupor
coma
death
within
day
toxinmedi
palat
paralysig
laryng
paralysi
ocular
palsi
diaphragmat
palsi
myocard
may
occur
accur
diagnosi
requir
isol
c
diphtheria
cultur
materi
beneath
membran
confirm
toxin
product
organ
isol
acut
symptomat
pharyng
caus
n
gonorrhoea
occur
occasion
sexual
activ
individu
consequ
oralgenit
contact
children
sexual
abus
must
suspect
infect
usual
present
ulcer
exud
tonsillopharyng
may
asymptomat
resolv
spontan
gonococc
occur
homosexd
men
heterosexu
women
fellatio
less
readili
acquir
cunnilingu
gonorrhea
rare
transmit
phatnx
sex
partner
pharyng
serv
sourc
gonococcemia
diagnosi
requir
cultur
appropri
select
media
eg
thayermartin
chlamydia
trachomati
implic
serolog
mani
adult
pharyng
isol
organ
pharynx
difficult
recent
chlamydia
pneumonia
formerli
name
twar
also
identifi
caus
pharyng
diagnosi
chlamydi
pharyng
difficult
whether
cultur
serolog
neither
method
readili
avail
clinician
mpneumonia
probabl
caus
pharyng
serolog
cultur
method
use
identifi
agent
chlamydi
mycoplasm
pharyng
diagnos
research
studi
nonstreptococc
pharyng
efficaci
antibiot
treatment
ill
known
appear
selflimit
certain
streptococci
group
capabl
caus
acut
pharyng
welldocu
epidem
foodborn
group
c
group
g
streptococc
pharyng
report
young
adult
role
nongroup
streptococc
organ
etiolog
agent
endem
acut
pharyng
difficult
establish
data
suggest
group
c
group
g
streptococci
respons
acut
pharyng
particularli
adolesc
gerber
et
report
outbreak
group
g
streptococc
pharyng
among
suburban
children
howev
exact
role
agent
carri
asymptomat
pharynx
remain
fulli
character
implic
agent
acut
pharyng
group
c
g
organ
appear
requir
treatment
caus
selflimit
infect
acut
rheumat
fever
sequel
infect
although
poststreptococc
nephriti
occur
rare
epidem
group
c
group
g
streptococc
pharyng
antibiot
therapi
greatli
reduc
suppur
complic
acut
group
streptococc
pharyng
caus
spread
pharynx
adjac
structur
peritonsillar
abscess
quinsi
present
fever
sever
throat
pain
dysphagia
hot
potato
voic
pain
refer
ear
bulg
peritonsillar
area
asymmetri
tonsil
displac
uvula
occasion
peritonsillar
cellul
without
welldefin
abscess
occur
abscess
found
clinic
imag
studi
comput
tomographi
scan
surgic
drainag
indic
retropharyng
abscess
repres
extens
infect
pharynx
peritonsillar
region
retropharyng
prevertebr
space
rich
lymphoid
structur
fever
dysphagia
drool
stridor
extens
neck
mass
posterior
pharyng
wall
may
note
surgic
drainag
requir
frank
suppur
occur
spread
streptococci
via
pharyng
lymphat
region
node
caus
cervic
lymphaden
suppur
otiti
media
mastoid
sinus
also
may
occur
complic
streptococcalpharyng
tabl
complic
includ
acut
rheumat
fever
acut
poststreptococc
glomerulonephr
probabl
reactiv
arthriti
synov
note
prevent
arf
subsequ
rheumat
heart
diseas
principl
reason
treat
streptococc
pharyng
therapi
appropri
antibiot
begun
within
day
onset
symptom
highli
effect
prevent
complic
acut
rheumat
fever
diagnos
use
clinic
criteria
first
formul
duckett
jone
latest
revis
jone
criteria
found
tabl
addit
evid
anteced
infect
group
streptococci
diagnosi
arf
requir
one
major
plu
two
minor
criteria
two
major
criteria
proof
infect
posit
throat
cultur
rapid
test
elev
antibodi
titer
least
one
extracellular
product
group
streptococcu
longterm
chronic
therapi
penicillin
sulfa
perhap
life
recommend
patient
histori
arf
rheumat
heart
diseas
prevent
recurr
attack
arf
poststreptococc
reactiv
arthriti
analog
postinfecti
reactiv
syndrom
without
featur
arf
probabl
occur
relationship
entiti
arf
unclear
patient
fulfil
jone
criteria
consid
arf
diagnos
exclud
manag
accordingli
incid
sever
arf
unit
state
mani
develop
countri
began
declin
earli
advanc
live
condit
sanit
nutrit
probabl
account
earli
declin
sinc
greater
access
medic
care
presum
lead
prompt
diagnosi
treatment
contribut
declin
arf
sinc
late
unexpect
local
region
cluster
arf
report
begin
outbreak
near
salt
lake
citi
mani
patient
outbreak
suburban
middleclass
children
mild
symptom
anteced
pharyng
incid
carditi
among
high
evid
group
streptococcu
strain
heavili
encapsul
produc
mucoidappear
coloni
blood
agar
associ
outbreak
although
thought
group
streptococci
equal
potenti
caus
acut
rheumat
fever
certain
strain
appear
particularli
rheumatogen
reason
local
resurg
arf
remain
fulli
elev
acut
phase
reactant
erythrocyt
sediment
rate
creactiv
protein
prolong
pr
interv
note
jone
criteria
revis
two
major
one
major
two
minor
criteria
suffic
diagnosi
support
evid
anteced
infect
ga
posit
throat
cultur
rapid
strep
test
elev
rise
antibodi
titer
elucid
may
relat
local
presenc
highli
rheumatogen
strain
group
streptococci
poststreptococc
agn
major
sequela
group
streptococc
infect
contrast
arf
agn
appear
prevent
prompt
treatment
anteced
streptococc
infect
pharyng
caus
nephritogen
strain
group
streptococci
preced
symptom
day
unlik
arf
occur
pharyng
agn
also
follow
skin
infect
agn
character
sudden
onset
edema
oliguria
hematuria
proteinuria
hypertens
diagnosi
poststreptococc
agn
requir
evid
prior
infect
group
streptococci
cultur
rapid
test
serolog
mean
hypocomplementemia
especi
decreas
support
diagnosi
pharyng
caus
group
streptococcu
requir
accur
diagnosi
time
treatment
prevent
acut
rheumat
fever
clinic
sign
symptom
often
distinguish
pharyng
caus
group
streptococci
pharyng
caus
microorgan
rapid
antigen
detect
throat
cultur
recommend
diagnosi
except
viral
sign
symptom
promin
therapi
penicillin
drug
choic
associ
prevent
rheumat
fever
rapid
clinic
improv
prompt
loss
contagi
bacteriolog
treatment
failur
occur
despit
univers
sensit
group
streptococci
penicillin
caus
treatment
failur
chronic
carriag
remain
determin
newer
expens
antibiot
substanti
enhanc
treatment
success
need
prescrib
patient
